# Telix IsoTherapeutics Group, Inc. – FDA Inspection, Feb 3, 2020

Source: https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/3bad0e48-0020-4669-bec4-7c1afc264c17
Source feed: FDA_Inspections

> FDA inspection 1117578 of Telix IsoTherapeutics Group, Inc., February 03, 2020. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117578
- Company Name: Telix IsoTherapeutics Group, Inc.
- Inspection Date: 2020-02-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1277105 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/00ed8c68-0d69-4e9f-a178-27095a6fa684)
- [FDA Inspection 1089897 - 2019-05-17](https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/66f046d1-c165-497a-b926-5a9a84ef4670)
- FDA Inspection 994402 - 2016-11-30

Company: https://www.keypedia.com/companies/telix-isotherapeutics-group-inc/4c1ef15c-5396-4f70-9e46-da410d1485cc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c